Holen Sie sich die Stockscreener-App
4.73
3.86%
-0.19
Handel nachbörslich:
4.82
0.09
+1.90%
Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
15.86%
43.96
|
52.25 | 71.15 | 64.39 | 69.42 |
| Interest Income/Expense |
0.00%
0.473
|
0.473 | 0.473 | 0.472 | 0.471 |
| Operating Income/Loss |
15.86%
-43.96
|
-52.25 | -71.15 | -64.39 | -69.42 |
| Income/Loss From Continuing Operations Before Tax |
15.49%
-42.54
|
-50.33 | -68.92 | -61.33 | -66.72 |
| Income/Loss From Continuing Operations After Tax |
15.49%
-42.54
|
-50.33 | -68.92 | -61.33 | -66.72 |
|
Net Income/Loss
|
15.49%
-42.54
|
-50.33 | -68.92 | -61.33 | -66.72 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.80%
0.2236
|
111.57 | 111.02 | 110.09 | 94.16 |
| Diluted Average Shares |
99.80%
0.2236
|
111.57 | 111.02 | 110.09 | 94.16 |
| Basic Earnings Per Share |
15.56%
-0.38
|
-0.45 | -0.62 | -0.56 | -0.71 |
| Diluted Earnings Per Share |
15.56%
-0.38
|
-0.45 | -0.62 | -0.56 | -0.71 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):